$8 million raised for Fluorotechnics IPO
Investment merit prevails in pessimistic market
Chief executive officer of Fluorotechnics Dr Duncan Veal said: "Succeeding in a float in this market demonstrates the prospects of the company, as only a very robust investment proposition attracts new capital in these times."
According to Fluorotechnics, the Sydney-based company has developed valuable IP based on proprietary research over the past decade and has a list of blue chip clients starting to buy its products. Fluorotechnics has specialised manufacturing facilities at North Ryde in Sydney and near Stuttgart in Germany. The company was established in 2002 and was spun-out of Macquarie University which remains a shareholder.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.